Research ArticleCancer therapy

MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)–addicted neuroblastomas

See allHide authors and affiliations

Science Signaling  28 Nov 2017:
Vol. 10, Issue 507, eaam7550
DOI: 10.1126/scisignal.aam7550
PDF Container

Stay Connected to Science Signaling

Navigate This Article